TVARDI THERAPEUTICS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
TVARDI THERAPEUTICS, INC. (TVRD) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $52.30 million as of 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-11-06
- 2018-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $52.30M.
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $86.14M.
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $58.15M.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $82.68M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2018-09-30 | $52.30M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $86.14M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $58.15M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $82.68M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $29.71M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $51.04M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $10.26M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $17.67M 10-K · filed 2018-03-15 |
| 2016-09-30 | $18.97M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $11.05M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $11.68M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $57.13M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |